10 Best Low Priced Biotech Stocks to Buy Now

8. Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)

Stock Price: $6.45

Number of Hedge Fund Holders: 36

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) develops and commercializes targeted therapies for genetically defined cancers in patients of all ages. Its products include DAY101 and pimsertib. It is the eighth-best low-priced biotech stock to buy now.

On May 7, analyst Andres Y. Maldonado from H.C. Wainwright reiterated a buy rating on the stock, keeping the price target at $36.00 and highlighting its promising trajectory. The analyst reasoned that the company’s OJEMDA product, which treats certain kinds of brain tumors, showed consistent growth, attaining considerable sequential revenue growth and a notable increase in cumulative prescriptions.

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is also advancing its pipeline through the FIREFLY-2 trial, which, according to the analyst, has the potential to bolster OJEMDA’s market position. The company has a robust strategy for long-term growth, which includes the promising early-stage development of its anti-PTK7 ADC and a focus on overcoming physician conservatism in pediatric oncology.